Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

Using continuous processing instead of batch-based processing provides therapeutic manufacturers with a number of advantages. For example, the continuous approach can ...

GE Healthcare’s ReadyToProcess WAVE 25 single-use bioreactor can be used for batch and perfusion cell culture processes. Now representing eight of the top 10 pharmaceuticals based on global sales, ...

Amid the chaos of the Covid-19 pandemic, governments across the globe began to worry about whether key medical goods would arrive to their shores on time. Considering the broader trend of rising ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

CordenPharma has joined the small but growing cadre of pharma companies adding continuous manufacturing to their mix of manufacturing operations for small-molecule drugs. The Germany-based CDMO has ...

With the right approach to continuous improvement, printing companies can thrive if they’re willing to make the investment. To be successful, a company must recognize that processes are the central ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Within the process industry, the chemical and pharmaceutical ...

This workshop will discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics, such as enzymes, monoclonal antibodies, and ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

Prolonged uncertainty doesn’t appear to be ending any time soon. In fact, it's become our new normal. Against this backdrop of persistent ambiguity, many business leaders now find themselves ...